Search
Now showing items 1-3 of 3
Studies of b-AP15 : a novel inhibitor of proteasome deubiquitinase activity
(2017-04-07)
Bortezomib was the first FDA approved proteasome inhibitor that was initially very successful in treatment of multiple myeloma patients but acquired resistance and adverse side-effect highly decreased patients’ quality of ...
Tuberculosis and HIV : evaluation of new tests for diagnostic accuracy, cost-effectiveness and effect on treatment of tuberculosis in Smear-Negative HIV-positive patients in Uganda
(2015-04-29)
Background: Despite tremendous progress in the control of the global tuberculosis (TB) epidemic during the past decade, it is
still a major health problem even today. The burden of TB is particularly severe in sub-Sahara ...
Delivery of DNA vaccines against cancer
(2006-10-06)
DNA vaccines against cancer have shown promising results in animal models. Efficient antigenspecific T cell responses and tumor protection have been demonstrated after vaccination with DNA encoding tumor antigens in mice. ...